Skip to main content
Free access
Methodology
16 June 2020

Analyzing the concept of spillover effects for expanded inclusion in health economics research

Abstract

Background: The incorporation of spillover effects in health economic research is recognized by regulatory agencies as useful for valuing health interventions and technologies. To date, spillover effects are not universally used within economic evaluations and conceptual definitions of spillover effects are vague within the context of health economics research. Materials & methods: In an effort to enhance awareness of spillover effects for health economic evaluations, a concept analysis using Walker and Avant’s approach was performed to elucidate the key attributes, definitions, antecedents and consequences of spillover effects across a range of disciplines. Results: Key attributes included lack of intention, positive and negative impacts, and two entity/domain involvement. Antecedents included an initial action and desired outcome. Consequences involved spillovers across industries, work life to personal life domains, patient to family member domains and across healthcare markets. Conclusion: The analysis provides greater clarification around the dimensions of spillover effects and reveals opportunities to enhance methodological approaches to assessing spillovers.

Formats available

You can view the full content in the following formats:

References

Papers of special note have been highlighted as: • of interest
1.
Kamal AH, Wolf SP, Troy J et al. Policy changes key to promoting sustainability and growth of the specialty palliative care workforce. Health Aff. 38(6), 910–918 (2019).
2.
Dowd B, Nyman JA. cost–effectiveness analysis in the context of us commercial health insurance. Pharmacoeconomics 37(6), 743–744 (2019).
3.
Ward MJ, Bonomo JB, Adeoye O et al. cost–effectiveness of diagnostic strategies for evaluation of suspected subarachnoid hemorrhage in the emergency department. Acad. Emerg. Med. 19(10), 1134–1144 (2012).
4.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. NY, USA, USA (2015).
5.
Sanders GD, Neumann J, Basu A et al. Recommendations for conduct, methodological practices and reporting of cost–effectiveness analyses: second panel on cost–effectiveness in health and medicine. JAMA 316(10), 1093–1103 (2016).
6.
Basu A, Meltzer D. Implications of spillover effects within the family for medical cost–effectiveness analysis. J. Health Econ. 24(4), 751–773 (2005).
7.
Gold M. Panel on cost–effectiveness in health and medicine. Med. Care 34(12), DS197–DS199 (1996).
8.
Sanders GD, Neumann PJ, Basu A et al. Recommendations for conduct, methodological practices and reporting of cost–effectiveness analyses: second panel on cost–effectiveness in health and medicine. JAMA 316(10), 1093–1103 (2016).
9.
Walker LO, Avant KC. Strategies for Theory Construction in Nursing. (4th Edition). Pearson Education, NJ, USA (2004).
10.
Lin PJ, D'Cruz B, Leech AA et al. 2019. Family and caregiver spillover effects in cost-utility analyses of Alzheimer's disease interventions. Pharmacoeconomics 37(4), 597–608 (2019).
11.
Tubeuf S, Saloniki EC, Cottrell D. Parental health spillover in cost–effectiveness analysis: evidence from self-harming adolescents in England. Pharmacoeconomics 37(4), 513–530 (2019).
• Used data from a randomized, controlled trial comparing two interventions for self-harming adolescents, family therapy with treatment as usual. Findings suggested that parents’ utility values increased throughout the duration of the trial and were positively associated with their adolescent's health status, measured by utility values.
12.
Wittenberg E, James LP, Prosser LA. Spillover effects on caregivers' and family members' utility: a systematic review of the literature. Pharmacoeconomics 37(4), 475–499 (2019).
13.
Grosse SD, Pike J, Soelaeman R, Tilford JM. Quantifying family spillover effects in economic evaluations: measurement and valuation of informal care time. Pharmacoeconomics 37(4), 461–473 (2019).
14.
Jacobs JC, Van Houtven CH, Tanielian T, Ramchand R. Economic spillover effects of intensive unpaid caregiving. Pharmacoeconomics 37(4), 553–562 (2019).
15.
Hurley J, Mentzakis E. Health-related externalities: evidence from a choice experiment. J. Health Econ. 32(4), 671–681 (2013).
16.
Baicker K, Robbins JA. Medicare payments and system-level health-care use: the spillover effects of Medicare managed care. Am. J. Health Econ. 1(4), 399–431 (2015).
17.
Brown CC, Tilford JM, Payakachat N et al. Measuring health spillover effects in caregivers of children with autism spectrum disorder: a comparison of the eq-5d-3l and sf-6d. Pharmacoeconomics 37(4), 609–620 (2019).
18.
Campbell JA, Ezzy D, Neil A et al. A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics. Health Econ. 27(8), 1300–1318 (2018).
• Cost–effectiveness analysis on bariatric surgery; authors finds positive human capital spillovers from patients reflecting positive self-worth into their productivity as an employee in the workplace after bariatric surgery.
19.
Canaway A, Al-Janabi H, Kinghorn P et al. Close-person spill-overs in end-of-life care: using hierarchical mapping to identify whose outcomes to include in economic evaluations. Pharmacoeconomics 37(4), 573–583 (2019).
20.
Hoefman RJ, van Exel J, Brouwer WBF. The monetary value of informal care: obtaining pure time valuations using a discrete choice experiment. Pharmacoeconomics 37(4), 531–540 (2019).
21.
McCabe C. Expanding the scope of costs and benefits for economic evaluations in health: some words of caution. Pharmacoeconomics 37(4), 457–460 (2019).
22.
Al-Janabi H, McLoughlin C, Oyebode J et al. Six mechanisms behind carer wellbeing effects: a qualitative study of healthcare delivery. Soc. Sci. Med. 235, 112382 (2019).
23.
Bhadhuri A, Jowett S, Jolly K et al. A comparison of the validity and responsiveness of the EQ-5D-5L and SF-6D for measuring health spillovers: a study of the family impact of meningitis. Med. Decis. Mak. 37(8), 882–893 (2017).
24.
Miller C, Pender J, Hertz T. Employment Spillover Effects of Rural Inpatient Healthcare Facilities. (Economic Research Report No. (ERR-241)) (2017). https://www.ers.usda.gov/publications/pub-details/?pubid=86253
25.
Brouwer WBF. The inclusion of spillover effects in economic evaluations: not an optional extra. Pharmacoeconomics 37(4), 451–456 (2019).
26.
Lakdawalla DN, Doshi JA, Garrison LP Jr, Phelps CE, Basu A, Danzon PM. Defining elements of value in health care – a health economics approach: an ISPOR Special Task Force Report. Value Health 21(2), 131–139 (2018).
27.
Johnson G, Figueroa JF, Zhou X, Orav EJ, Jha AK. Recent growth in Medicare Advantage enrollment associated with decreased fee-for-service spending in certain US counties. Health Affairs 35(9), 1707–1715 (2016).
28.
Arora S, Goodall S, Viney R et al. Using discrete-choice experiment methods to estimate the value of informal care: the case of children with intellectual disability. Pharmacoeconomics 37(4), 501–511 (2019).
29.
Galizzi MM, Whitmarsh L. How to measure behavioral spillovers: a methodological review and checklist. Front. Psychol. 10, 342 (2019).
30.
Kunst JR, Løset GK, Hosøy D et al. The relationship between shift work schedules and spillover in a sample of nurses. Int. J. Occup. Saf. Ergon. 20(1), 139–147 (2014).
31.
Zhou ZE, Meier LL, Spector PE. The spillover effects of coworker, supervisor and outsider workplace incivility on work-to-family conflict: a weekly diary design. J. Organizational Behav. 40(9–10), 1000–1012 (2019).
32.
Amstad FT, Semmer NK. Spillover and crossover of work-and family-related negative emotions in couples. Psychol. Everyday Activity 4(1), 43–55 (2011).
33.
Jones CR, Whitmarsh LE, Byrka K et al. Methodological, theoretical and applied advances in behavioural spillover. Front. Psychol. 10, 2701 (2019).
34.
Nash N, Whitmarsh L, Capstick S et al. Climate-relevant behavioral spillover and the potential contribution of social practice theory. WIREs Clim. Change 8, e481 (2017).
35.
Aranda E, Menjívar C, Donato KM. The spillover consequences of an enforcement-first u.s. immigration regime. Am. Behav. Sci. 1687–1695 (2014).
36.
Hagan J, Foster H. Children of the american prison generation: student and school spillover effects of incarcerating mothers. Law Soc. Rev. 46(1), 37–69 (2012).
37.
Timmermans S, Orrico LA, Smith J. Spillover effects of an uninsured population. J. Health Soc. Behav. 55(3), 360–374 (2014).
• Uses open-interviewing, qualitative methods to elucidate the effects of a lack of insurance on two institutions, churches and schools. Negative spillover effects noted with increased absenteeism within schools, while less spillovers were noted in religious institutions.
38.
Braga AA, Zimmerman G, Barao L, Farrell C, Brunson RK, Papachristos AV. Street gangs, gun violence and focused deterrence: comparing place-based and group-based evaluation methods to estimate direct and spillover deterrent effects. J. Res. Crime Delinquency 56(4), 524–562 (2019).
39.
Frischmann BM, Lemley MA. Spillovers. Colum. L. Rev. 107, 257 (2007).
40.
Sahni NS. Advertising spillovers: evidence from online field experiments and implications for returns on advertising. J. Marketing Res. 53(4), 459–478 (2016).
41.
Grillitsch M, Nilsson M. Innovation in peripheral regions: do collaborations compensate for a lack of local knowledge spillovers? Ann. Reg. Sci. 54(1), 299–321 (2015).
43.
Jemna LM. Qualitative and mixed research methods in economics: the added value when using qualitative research methods. J. Public Admin. Finance Law 154–67 (2016).
44.
Dopp AR, Mundey P, Beasley LO et al. Mixed-method approaches to strengthen economic evaluations in implementation research. Implement. Sci. 14(1), 1–9 (2019).
• Overview of qualitative methodological integration into mixed methods research. Asserts that elucidation of patient preferences can be overlooked when qualitative investigations are omitted from economic evaluations.
45.
Brazier J, Roberts J, Tsuchiya A. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13(9), 873–884 (2004).
46.
Brooks R, Group E. EuroQol: the current state of play. Health Pol. 37(1), 53–72 (1996).
47.
Husbands S, Jowett S, Barton P et al. How qualitative methods can be used to inform model development. Pharmacoeconomics 35(6), 607–612 (2017).
48.
Kauffman KS. The insider/outsider dilemma: field experience of a white researcher “getting in” a poor black community. Nursing Res. 43(3), 179–183 (1994).
49.
Wolcott HF. On ethnographic intent. Educat. Admin. Q 21(3), 187–203 (1985).
50.
Lincoln YS, Guba EG. Naturalistic Inquiry. Sage Publications Inc., CA, USA (1985).
51.
Siebert U, Alagoz O, Bayoumi AM et al. Conceptualizing a model: a report of the ispor-smdm modeling good research practices task force-2 mark. Med. Decis. Mak. 32(5), 678–689 (2012).
52.
Coast J. Qualitative methods for health economics. Rowman & Littlefield, MD, USA, 261–270 (2009).
• Systematic review article evaluates the use of economic evaluations for decision making on a national and local (within hospitals or among providers) level. Institutional, methodological and cultural factors influences the use of economic evaluations for decision-making.